Conference talk on SIRT6, DNA repair, the dark genome and inflammation in ageing
In this conference description, Professors Gorbunova and Seluanov present research on DNA repair, SIRT6, fucoidan, inflammageing and LINE-1 elements; the video and transcript were not reviewed. [1]
Automatic summary · not editorially reviewed
The key findings
The description says SIRT6 is more active in long-lived species and in some human centenarians. [1]
The description says mouse research showed that suppressing LINE-1 reduced inflammation and frailty. [1]
The description says a clinical trial in older adults is under way in Singapore, supported in part by DoNotAge.org. [1]
The source at a glance
- Study type / format
- Video description of a conference session
- Population / context
- Not specified in the description; research described includes cells, ageing mice, long-lived species, human centenarians and older adults in a Singapore trial.
- Summary based on
- Creator description
- Original publication
- October 7, 2026
Gorbunova on SIRT6 and long-lived species
According to the description, Gorbunova asks why a naked mole rat lives more than 40 years while a mouse lives two or three, and what this says about healthy ageing in humans. She describes SIRT6 as a key DNA repair protein that is more active in long-lived species and in some human centenarians. Her lab's work on fucoidan from brown seaweed is also listed, including batch testing of SIRT6Activator® and findings in ageing mice on frailty, epigenetic age and lifespan. A clinical trial in older adults is described as under way in Singapore, supported in part by DoNotAge.org. The description does not report results of that trial.
Supporting source [1]
Seluanov on inflammageing and LINE-1 in mice
The description says Seluanov explores inflammageing, the low-grade chronic inflammation that builds up with age. He also discusses the "dark genome": around half of our DNA is said to consist of transposable elements, and LINE-1 elements are described as reactivating as we age. Research in mice is said to show that suppressing LINE-1 reduced inflammation and frailty. What comes next is described as new research into safer compounds that target transposons, and antiviral drugs are mentioned as being repurposed to block transposons. These are described as research directions and animal findings, not as established benefits for human lifespan.
Supporting source [1]
Scope of this conference description
This text is a video description for a DoNotAge.org Conference 2026 session in London, closing with a plain-English summary by founder Alan Graves. It lists chapter topics and links to SIRT6Activator® as one of 15 longevity ingredients in a DoNotAge® product. The description does not give study designs, sample sizes, effect sizes or full results, and it does not establish that any ingredient or compound extends human lifespan. The video and transcript were not reviewed, so details beyond the description are unknown.
Supporting source [1]
How to interpret this
Only the video description was supplied; the video and transcript were not reviewed. No study designs, sample sizes, effect sizes or full results are given, and no human lifespan benefit is established.
Based on the creator’s description; the full video and transcript were not analyzed.
Source & supporting passages
DoNotAge · youtube.com · October 7, 2026